AU2001231663A1 - Pharmaceutical preparation containing specific pde v inhibitors - Google Patents

Pharmaceutical preparation containing specific pde v inhibitors

Info

Publication number: AU2001231663A1
Authority: AU; Australia
Prior art keywords: inhibitors; pharmaceutical preparation; preparation containing; containing specific; specific pde
Prior art date: 2000-01-13
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2001231663A

Inventor

Karen Schamp

Sven Schreder

Claudia Wildner

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Merck Patent GmbH

Original Assignee

Merck Patent GmbH

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-01-13

Filing date

2001-01-05

Publication date

2001-07-24

2001-01-05 Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH

2001-07-24 Publication of AU2001231663A1 publication Critical patent/AU2001231663A1/en

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

AU2001231663A 2000-01-13 2001-01-05 Pharmaceutical preparation containing specific pde v inhibitors Abandoned AU2001231663A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DE10001021		2000-01-13
DE2000101021 DE10001021A1 (en)	2000-01-13	2000-01-13	Pharmaceutical preparation
PCT/EP2001/000082 WO2001051052A1 (en)	2000-01-13	2001-01-05	Pharmaceutical preparation containing specific pde v inhibitors

Publications (1)

Publication Number	Publication Date
AU2001231663A1 true AU2001231663A1 (en)	2001-07-24

Family

ID=7627303

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2001231663A Abandoned AU2001231663A1 (en)	2000-01-13	2001-01-05	Pharmaceutical preparation containing specific pde v inhibitors

Country Status (4)

Country	Link
AR (1)	AR027513A1 (en)
AU (1)	AU2001231663A1 (en)
DE (1)	DE10001021A1 (en)
WO (1)	WO2001051052A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10107261B4 (en) *	2001-02-16	2005-03-10	Merck Patent Gmbh	Pharmaceutical composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PH31122A (en) *	1993-03-31	1998-02-23	Eisai Co Ltd	Nitrogen-containing fused-heterocycle compounds.
DE19644228A1 (en) *	1996-10-24	1998-04-30	Merck Patent Gmbh	Thienopyrimidines
DE19819023A1 (en) *	1998-04-29	1999-11-04	Merck Patent Gmbh	Thienopyrimidines
DE19928146A1 (en) *	1999-06-19	2000-12-21	Merck Patent Gmbh	New 3-benzylamino-benzothienopyrimidine derivatives inhibit phosphodiesterase V and are useful for treating cardiac insufficiency and impotence

2000
- 2000-01-13 DE DE2000101021 patent/DE10001021A1/en not_active Withdrawn
2001
- 2001-01-05 AU AU2001231663A patent/AU2001231663A1/en not_active Abandoned
- 2001-01-05 WO PCT/EP2001/000082 patent/WO2001051052A1/en not_active Ceased
- 2001-01-12 AR ARP010100136A patent/AR027513A1/en unknown

Also Published As

Publication number	Publication date
AR027513A1 (en)	2003-04-02
WO2001051052A1 (en)	2001-07-19
DE10001021A1 (en)	2001-07-19

Similar Documents

Publication	Publication Date	Title
AU2001235691A1 (en)	2001-08-27	Use of paullone derivatives for making medicines
AU781269C (en)	2006-11-30	Pharmaceutical compositions
AU2001289751A1 (en)	2002-02-13	Selective pde 2 inhibitors, used as medicaments for improving cognition
AU2001237526A1 (en)	2001-11-22	Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof
AU2001264313A1 (en)	2002-01-02	Pyrazolopyridine compounds and use thereof as drugs
AU2001280188A1 (en)	2002-03-13	Pyrazolopyridine compound and pharmaceutical use thereof
AU2001250420A1 (en)	2001-10-23	Pharmaceutical compositions
AU2001274307A1 (en)	2002-01-02	Pharmaceutical compositions
AU2001244355A1 (en)	2001-10-15	Heterobiarylsulphonamides and their use as pde 7 inhibitors
AU2001292185A1 (en)	2002-04-22	Formulation containing amoxicillin
AU2001295657A1 (en)	2002-04-22	Formulation containing wax-esters
HUP0303279A3 (en)	2004-11-29	Indolylopyrrolocarbazoles sugar derivatives as topoisomerase inhibitors and pharmaceutical compositions containing them
AU2002232468A1 (en)	2002-07-01	Pharmaceutical heterocyclic compounds
AU2001273919A1 (en)	2001-10-23	Pharmaceutical compositions
AU2002241211A1 (en)	2002-10-15	Imidazo-triazine derivatives as pde 5 inhibitors
AU2001284763A1 (en)	2002-02-18	Preparation of risperidone
AU3945501A (en)	2001-09-17	Apparatus for dosage of medicaments
AU4085201A (en)	2001-09-24	Pharmaceutical composition
AU2001231663A1 (en)	2001-07-24	Pharmaceutical preparation containing specific pde v inhibitors
AU2001292578A1 (en)	2002-04-15	Pharmaceutical compounds
AU3586401A (en)	2001-09-17	Pharmaceutical composition
AU2001264900A1 (en)	2001-12-03	Pharmaceutical use of fibulin-1
AU2002333235A1 (en)	2003-05-22	Pharmaceutical formulation containing an LTB4 antagonist
AU2001278705A1 (en)	2002-02-25	Pharmaceutical composition
AU2001259564A1 (en)	2002-01-21	Pharmaceutical compositions and methods for use